5AM Ventures IV L.P. 13D and 13G filings for scPharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:25 pm Sale |
2023-12-31 | 13G | scPharmaceuticals Inc. SCPH |
5AM Ventures IV L.P. | 1,200,647 3.300% |
-1,534,205 (-56.10%) |
Filing |
| 2023-02-14 4:04 pm Sale |
2022-12-31 | 13G | scPharmaceuticals Inc. SCPH |
5AM Ventures IV L.P. | 2,734,852 8.000% |
-1,096,622 (-28.62%) |
Filing |
| 2021-02-16 06:30 am Purchase |
2020-12-31 | 13G | scPharmaceuticals Inc. SCPH |
5AM Ventures IV L.P. | 3,831,474 14.000% |
578,034 (+17.77%) |
Filing |